Cargando…
2-Chlorodeoxyadenosine treatment for cutaneous T-cell lymphoma
The primary cutaneous lymphomas are often indolent but difficult to treat. In the early stages psoralen and ultraviolet-A therapy is the standard treatment whereas at the tumor stage chemotherapy (e.g. pegylated doxorubicin) is often used for debulking. The purine analog 2-chlorodeoxyadenosine (2CdA...
Autores principales: | Sokołowska-Wojdyło, Małgorzata, Trzeciak, Magdalena, Roszkiewicz, Jadwiga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211472/ https://www.ncbi.nlm.nih.gov/pubmed/25386249 http://dx.doi.org/10.4081/dr.2010.e12 |
Ejemplares similares
-
Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas
por: Kołkowski, Karol, et al.
Publicado: (2021) -
The role of polymorphism of interleukin-2, -10, -13 and TNF-α genes in cutaneous T-cell lymphoma pathogenesis
por: Nedoszytko, Boguslaw, et al.
Publicado: (2016) -
Safety and danger of biologic treatments in psoriasis in context of cutaneous T-cell lymphoma (CTCL)
por: Kołkowski, Karol, et al.
Publicado: (2021) -
Primary cutaneous lymphomas: diagnosis and treatment
por: Sokołowska-Wojdyło, Małgorzata, et al.
Publicado: (2015) -
Expression Profiles of Genes Encoding Cornified Envelope Proteins in Atopic Dermatitis and Cutaneous T-Cell Lymphomas
por: Trzeciak, Magdalena, et al.
Publicado: (2020)